Zeke Capital Advisors, LLC Zynerba Pharmaceuticals, Inc. Transaction History

Zeke Capital Advisors, LLC

  • $1.53 Billion
  • Q4 2022

A detailed history of Zeke Capital Advisors, LLC transactions in Zynerba Pharmaceuticals, Inc. stock. As of the latest transaction made, Zeke Capital Advisors, LLC holds 49,700 shares of ZYNE stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,700
Previous 49,700 -0.0%
Holding current value
$0
Previous $36,000 27.78%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 09, 2020
SELL
$3.23 - $4.3 $1.27 Million - $1.69 Million
-392,404 Reduced 88.76%
49,700 $165,000
Q2 2020

Jul 21, 2020
BUY
$3.31 - $6.54 $132,042 - $260,893
39,892 Added 9.92%
442,104 $1.49 Million
Q3 2019

Oct 18, 2019
SELL
$7.56 - $15.44 $68,040 - $138,960
-9,000 Reduced 2.19%
402,212 $3.04 Million
Q2 2019

Jul 24, 2019
BUY
$5.4 - $15.5 $2.09 Million - $6.01 Million
387,512 Added 1635.07%
411,212 $5.57 Million
Q3 2018

Nov 08, 2018
BUY
$5.59 - $10.45 $132,483 - $247,664
23,700 New
23,700 $193,000
Q4 2017

Feb 14, 2018
SELL
$8.69 - $14.59 $118,184 - $198,424
-13,600 Closed
0 $0
Q3 2017

Nov 09, 2017
BUY
$5.73 - $9.44 $77,928 - $128,384
13,600
13,600 $114,000

Others Institutions Holding ZYNE

# of Institutions
5
Shares Held
787K
Call Options Held
0
Put Options Held
0
View Full List

About Zynerba Pharmaceuticals, Inc.

ZYNE Quotes by TradingView
  • Ticker ZYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,753,100
  • Description
  • Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...
More about ZYNE
Track This Portfolio

Track Zeke Capital Advisors, LLC Portfolio

Follow Zeke Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email